C37H41FN8O5 — CID 176641309
N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide (PubChem CID 176641309) has the molecular formula C37H41FN8O5 and a molecular weight of 696.78 g/mol. Its IUPAC name is N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide.
| Compound Name | N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide |
|---|---|
| PubChem CID | 176641309 |
| Molecular Formula | C37H41FN8O5 |
| Molecular Weight | 696.78 g/mol |
| Exact Mass | 696.32 |
| IUPAC Name | N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide |
| SMILES | Cc1nc(C(=O)Nc2ccc3nn(C4CCC(CN5CC[C@@H](c6cccc7c6n(C)c(=O)n7C6CCC(=O)NC6=O)[C@H](F)C5)CC4)cc3c2)co1 |
| InChI | InChI=1S/C37H41FN8O5/c1-21-39-30(20-51-21)35(48)40-24-8-11-29-23(16-24)18-45(42-29)25-9-6-22(7-10-25)17-44-15-14-26(28(38)19-44)27-4-3-5-31-34(27)43(2)37(50)46(31)32-12-13-33(47)41-36(32)49/h3-5,8,11,16,18,20,22,25-26,28,32H,6-7,9-10,12-15,17,19H2,1-2H3,(H,40,48)(H,41,47,49)/t22?,25?,26-,28+,32?/m0/s1 |
| InChIKey | BZOITCCXTOTVEP-SOIACLJCSA-N |
| XLogP | 4.78 |
| TPSA | 149.29 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 51 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 696.78 |
| LogP ≤ 5 | 4.78 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 11 |
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|